Late-stage melanoma: Experimental drug combo puts 50% of patients into remission

  • Researchers tested the efficacy of a drug combination for treating stage IV melanoma.
  • They found that 71% of patients responded to the drug combination, and 50% had complete remission.
  • The drug combination is now entering a larger trial with a more diverse cohort.

By Annie Lennon on January 3, 2023

Fact checked by Harriet Pike, Ph.D.

read full article

Call us at (888)-243-6602 to discuss how we can help keep your loved one safe and happy at home.